DOI: https://doi.org/10.24959/sphhcj.17.93

The study of the prevalence and incidence of Parkinson’s disease in different world regions

A. A. Kotvitska, O. S. Prokopenko

Abstract


Aim. To study the prevalence and incidence of Parkinson’s disease in 5 world regions and rank them by indexes of the prevalence and incidence.

Materials and methods. Methods of scientific analysis, in particular analytical, statistical methods and the content analysis, were used in this work.

Results. The indicators of the prevalence and incidence of Parkinson’s disease in different countries and regions, as well as for different age groups have been determined. It has been shown that the number of patients with Parkinson’s disease increases exponentially with age, i.e. starting from the age of 55 the number of patients increases sharply. It has been found that one of the factors affecting the prevalence of Parkinson’s disease is the state of the environment, in particular the air pollution.

Conclusions. According to the study conducted it has been determined that Parkinson’s disease is spreading unevenly in the world and in individual countries. The data obtained will be used for further research of Parkinson’s disease.


Keywords


Parkinson’s disease; prevalence; incidence; international experience

References


1. Blin, P., Dureau-Pournin, C., Foubert-Samier, A., Grolleau, A., Corbillon, E., Jové, J., Lassalle, R., Robinson, P., Poutignat, N., Droz-Perroteau, C., Moore, N. (2014). Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database. European Journal of Neurology, 22(3), 464–471. doi: 10.1111/ene.12592.

2. Razdorskaya, V. V., Voskresenskaya, O. N., Yudina, G. K. (2016). Bolezn Parkinsona v Rosii: Rasprostranennost i zabolevaemost. Saratov Journal of Medical Scientific Research, 12(3), 379–384.

3. Duncan, G. W., Khoo, T. K., Coleman, S. Y. et al. (2014). The incidence of Parkinson’s disease in the North-East of England. Age and Ageing, 43(2), 257–263. doi: 10.1093/ageing/aft091

4. Pupillo, E., Cricelli, C., Mazzoleni, F., Cricelli, I., Pasqua, A., Pecchioli, S., Lapi, F., Beghi, E. (2016). Epidemiology of Parkinson’s Disease: A Population-Based Study in Primary Care in Italy. Neuroepidemiology, 47(1), 38–45. doi: 10.1159/000448402.

5. Nerius, M., Fink, A., Doblhammer, G. (2017). Parkinson’s disease in Germany: prevalence and incidence based on health claims data. Acta Neurologica Scandinavica, 136(5), 386–392. doi: 10.1111/ane.12694.

6. Nerius, M., Fink, A., Doblhammer-Reiter, G. (2015). Parkinson’s Disease in Germany: Prevalence, Incidence and Mortality Based on Health Claims Data. Rostock Center – Discussion Paper, 32, 4–21.

7. Horsfall, L., Petersen, I., Walters, K., Schrag, A. (2012). Time trends inincidence of Parkinson’s disease diagnosis in UK primary care. Journal of Neurology, 260(5), 1351–1357. doi: 10.1007/s00415-012-6804-z.

8. Liu, C., Li, C., Lee, P., Sun, Y. (2016). Variations in Incidence and Prevalence of Parkinson’s Disease in Taiwan: A Population-Based Nationwide Study. Parkinson’s Disease, 2016, 1–8. doi: 10.1155/2016/8756359.

9. Akanova, A., Kamenova, S., Pichkhadze, G. (2014). Vestnik KazNMU, 4, 441–444.

10. Ma, C., Su, L., Xie, J., Long, J., Wu, P., Gu, L. (2014). The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis. Journal of Neural Transmission, 121(2), 123–134. doi: 10.1007/s00702-013-1092-z.

11. Van Den Eeden, S., Tanner, C. M., Bernstein, A. L. et al. (2003). Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity. American Journal of Epidemiology, 157(11), 1015–1022. doi: 10.1093/aje/kwg068.

12. Mehta, P., Kifley, A., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Population prevalence and incidence of Parkinson’s disease in an Australian community. Internal Medicine Journal, 37(12), 812–814. doi: 10.1111/j.1445-5994.2007.01433.x.

13. Statistic’s of Parkinson’s disease Canada. Retrieved from: http://www.parkinson.ca/atf/cf/%7B9ebd08a9-7886-4b2d-a1c4-a131e7096bf8%7D/STATISTICSONPARKINSON_EN.DOCX.

14. Wong, S., Gilmour, H. andRamage-Morin, P. (2014). Parkinson’s disease: Prevalence, diagnosis and impact. Health Reports, 25(11), 10–14.

15. Caradoc-Davies, T., Weatherall, M., Dixon, G., Caradoc-Davies, G., Hantz, P. (1992). Is the prevalence of Parkinson’s disease in New Zealand really changing? Acta Neurologica Scandinavica, 86(1), 40–44. doi: 10.1111/j.1600-0404.1992.tb08051.x.

16. Okubadejo, N., Bower, J., Rocca, W., Maraganore, D. (2006). Parkinson’s disease in Africa: A systematic review of epidemiologic and genetic studies. Movement Disorders, 21(12), 2150–2156. doi: 10.1002/mds.21153.

17. Badry, R., Nagiub, H., Farghaly, W., Shehata, G., Rageh, T., Abdel-Hakeem, N., Abd Al Hamed, M., Badry, R. (2013). Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt. Neuropsychiatric Disease and Treatment, 9, 1821–1826. doi: 10.2147/NDT.S483181821.

18. Akinyemi, R. (2012). Epidemiology of Parkinsonism and Parkinson’s disease in Sub-Saharan Africa: Nigerian profile. Journal of Neurosciences in Rural Practice, 3(3), 233–234. doi: 10.4103/0976-3147.102586.


GOST Style Citations


1. Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database / P. Blin, C. Dureau-Pournin, A. Foubert-Samier et al. // European Journal of Neurology. – 2015. – Vol. 22, Issue 3. – P. 464–471. doi : 10.1111/ene.12592.

2. Раздорская, В. В. Болезнь Паркинсона в России: распространенность и заболеваемость / В. В. Раздорская, О. Н. Воскресенская, Г. К. Юдина // Saratov Journal of Medical Scientific Research. – 2016. – Т. 12, № 3. – С. 379–384.

3. The incidence of Parkinson’s disease in the North-East of England / G. W. Duncan, T. K. Khoo, S. Y. Coleman et al. // Age and Ageing. – 2014. – Vol. 43, Issue 2. – P. 257–263. doi : 10.1093/ageing/aft091.

4. Epidemiology of Parkinson’s Disease: A Population-Based Study in Primary Care in Italy / E. Pupillo, C. Cricelli, F. Mazzoleni et al. // Neuroepidemiology. – 2016. – Vol. 47, № 1. – P. 38–45. doi : 10.1159/000448402.

5. Nerius, M. Parkinson’s disease in Germany: prevalence and incidence based on health claims data / M. Nerius, A. Fink, G. Doblhammer // Acta Neurologica Scandinavica. – 2017. – Vol. 136, Issue 5. – P. 386–392. doi : 10.1111/ane.12694.

6. Nerius, M. Parkinson’s Disease in Germany: Prevalence, Incidence and Mortality Based on Health Claims Data / M. Nerius, A. Fink, G. Doblhammer-Reiter // RostockCenter – DiscussionPaper. – 2015. – № 32. – P. 4–21.

7. Time trends inincidence of Parkinson’s disease diagnosis in UK primary care / L.Horsfall, I. Petersen, W. Kate, A. Schrag // Journal of Neurology. – 2013. – Vol. 260, Issue 5. – P. 1351–1357. doi : 10.1007/s00415-012-6804-z.

8. Variations in Incidence and Prevalence of Parkinson’s Disease in Taiwan: A Population-Based Nation wide Study / L.Chih-Ching, L. Chung-Yi, L. Pei-Chen, S. Yu. // Parkinson’s Disease. – 2016. – Vol. 2016. – P. 1–8. doi : 10.1155/2016/8756359.

9. Современное состояние проблемы болезни Паркинсона в Казахстане / А. А. Аканова, С. У. Каменова, Г. М. Пичхадзе и др. // Вестник КазНМУ. – 2014. – № 4. – С. 441–444.

10. The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis / C. Ma, L. Su, J. Xie et al. // Journal of Neural Transmission. – 2014. – Vol. 121, Issue 2. – С. 123–134. doi : 10.1007/s00702-013-1092-z.

11. Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity / S. K. Van Den Eeden, C. M. Tanner, A. L. Bernstein et al. // American Journal of Epidemiology. – 2003. – Vol. 157, Issue 11. – С. 1015–1022. doi : 10.1093/aje/kwg068.

12. Population prevalence and incidence of Parkinson’s disease in an Australian community / P. Mehta, A. Kifley, J. Wang et al. // Internal Medicine Journal. – 2007. – Vol. 37, Issue 12. – P. 812–814. doi : 10.1111/j.1445-5994.2007.01433.x.

13. Statistic’s of Parkinson’s disease Canada [Internet]. – Retrieved from : http://www.parkinson.ca/atf/cf/%7B9ebd08a9-7886-4b2d-a1c4-a131e7096bf8%7D/STATISTICSONPARKINSON_EN.DOCX.

14. Wong, S. Parkinson’s disease: Prevalence, diagnosis and impact / S. Wong, H. Gilmour, P. Ramage-Morin // Health Reports. – 2014. – Vol. 25, № 11. – P. 10–14.

15. Is the prevalence of Parkinson’s disease in New Zealand really changing? / T. H. Caradoc-Davies, M. Weatherall, G. S. Dixon et al. // Acta Neurologica Scandinavia. – 1992. – Vol. 86, Issue 1. – P. 40–44. doi : 10.1111/j.1600-0404.1992.tb08051.x.

16. Parkinson’s Disease in Africa: A Systematic Review of Epidemiologic and Genetic Studies / N. U. Okubadejo, J. H. Bower, W. A. Rocca et al. // Movement Disorders. – 2006. – Vol. 21, Issue 12. – P. 2150–2156. doi : 10.1002/mds.21153.

17. Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt / H. N EL-Tallawy, W. M Farghaly, G. A Shehata et al. // Neuropsychiatric Disease and Treatment. – 2013. – Vol. 9. – P. 1821–1826. doi : 10.2147/NDT.S48318.

18. Akinyemi R. O. Epidemiology of Parkinsonism and Parkinson’s disease in Sub-Saharan Africa: Nigerian profile / R. Akinyemi // Journal of Neurosciences in Rural Practice. – 2012. – Vol. 3, Issue 3. – P. 233–234. doi : 10.4103/0976-3147.102586.

References





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Soc. farm. ohor. zdor.

ISSN 2518-1564 (Online), ISSN 2413-6085 (Print)